期刊文献+

人中性粒细胞明胶酶相关脂质运载蛋白与2型肝肾综合征患者预后的关系 被引量:4

Effect of neutrophil gelatinase-associated lipocalin on prognosis of patients with type 2 hepatorenal syndrome
原文传递
导出
摘要 目的 探讨人中性粒细胞明胶酶相关脂质运载蛋白(NGAL)与2型肝肾综合征(HRS)患者预后的关系. 方法 以54例2型HRS患者为研究对象,并对其随访6个月,根据随访情况,分为生存组25例和死亡组29例,单因素分析比较血、尿NGAL,血肾素、醛固酮及肝功能生物化学指标的差异,采用Cox比例风险回归模型进行多因素分析寻找2型HRS患者预后的影响因素.计量资料组间比较用t检验,多组间比较用方差分析;计数资料以相对数表示,组间比较用x2检验;相关分析采用Pearson相关分析;生存分析采用Cox比例风险回归模型的前进法. 结果 HRS组血红蛋白、血小板、白蛋白水平显著低于肝硬化组和对照组,差异均有统计意义(P< 0.05);HRS组INR、AST,ALT、总胆红素、直接胆红素、血肌酐、血NGAL、尿NGAL、血肾素和血醛固酮水平显著高于肝硬化组和对照组,差异均有统计意义(P< 0.05);血、尿NGAL与血肾素、血醛固酮、血肌酐、MELD评分、Child-Pugh评分和腹水等级均呈显著正相关(P<0.05);生存组白蛋白、血钠、血肌酐、血NGAL、尿NGAL、血肾素、血醛固酮水平均显著低于死亡组,肾小球滤过率显著高于死亡组,差异均有统计学意义(P< 0.05);Cox比例风险回归模型结果表明对2型HRS患者6个月生存情况有显著影响的预后因素为MELD评分、血NGAL、总胆红素和血肌酐,其相对危险度分别为1.214、1.157、1.098和1.016.结论 血NGAL在2型HRS患者中明显升高,是可预测其死亡风险的重要指标. Objective To investigate the effect of neutrophil gelatinase-associated lipocalin (NGAL) on prognosis of patients with type 2 hepatorenal syndrome (HRS).Methods A total of 54 patients with type 2 HRS were included in the study,and stratified for analysis according to survival status at 6-month followup:survival group,n =25; death group,n =29.Single factor analysis was used to compare the betweengroup differences for levels of plasma NGAL,urine NGAL,renin,aldosterone,and blood biochemical indicators.The Cox proportional hazard regression model was used to assess the prognosis of patients with type 2 HRS.The F-test,t-test,chi-square test,Pearson's correlation analysis,and Cox regression model were used for the statistical analyses.Results The HRS patients with liver cirrhosis showed significantly lower levels of hemoglobin,platelets and albumin (all P 〈 0.05),but significantly higher international normalized ratio and levels of aspartate aminotransferase,alanine arninotransferase,total bilirubin,direct bilirubin,serum creatinine,plasma NGAL,urine NGAL,renin and aldosterone (all P 〈 0.05).Plasma NGAL and urine NGAL were positively correlated with renin,aldosterone,blood creatinine,MELD score,Child-Pugh score and ascites (P 〈 0.05).The patients in the 6-month survival group showed significantly lower levels of albumin,serum sodium,serum creatinine,plasma NGAL,urine NGAL,renin,and aldosterone than those in the death group (P 〈 0.05),but significantly higher glomerular filtration rate (vs.death group,P 〈 0.05).The Cox proportional hazard regression model showed that MELD,plasma NGAL,total bilirubin and creatinine were influencing factors of 6-month prognosis for patients with type 2 HRS (relative risk:1.214,1.157,1.098 and 1.016 respectively).Conclusion Plasma NGAL is high in patients with type 2 FHRS,and is associated with risk of death.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2015年第6期449-453,共5页 Chinese Journal of Hepatology
关键词 肝肾综合征 预后 人中性粒细胞明胶酶相关脂质运载蛋白 Hepatorenal syndrome Prognosis Neutrophil gelatinase-associated lipocalin
  • 相关文献

参考文献12

  • 1Michele Orditura,Gennaro Galizia,Vincenzo Sforza,Valentina Gambardella,Alessio Fabozzi,Maria Maddalena Laterza,Francesca Andreozzi,Jole Ventriglia,Beatrice Savastano,Andrea Mabilia,Eva Lieto,Fortunato Ciardiello,Ferdinando De Vita.Treatment of gastric cancer[J].World Journal of Gastroenterology,2014,20(7):1635-1649. 被引量:118
  • 2Schrier RW, Shchekochikhin D, Gin6s P. Renal failure in cirrhosis: prerenal azotemia, hepatorenal syndrome and acute tubular necrosis[J]. Nephrol Dial Transplant, 2012, 27(7): 2625-2628.
  • 3Donadio C. Effect of glomerular filtration rate impairment on diagnostic performance of neutrophil gelafinase-associated lipocalin and B-type natriuretic peptide as markers of acute cardiac and renal failure in chronic kidney disease patients[J]. Crit Care, 2014, 18(1): R39.
  • 4Verna EC, Brown RS, Farrand E, et al. Urinary neutrophil gelatinase- associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis[J]. Dig Dis Sei, 2012, 57(9): 2362-2370.
  • 5Gungor G, Ataseven H, Demir A, et al. Neutrophil gelatinase- associated lipocalin in prediction of mortality in patients with hepatorenal syndrome: a prospective observational study[J]. Liver Int, 2014, 34(1): 49-57.
  • 6European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis[J]. J Hepatol, 2010, 53(3): 397-417.
  • 7Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices[J]. Br J Surg, 1973, 60(8): 646-649.
  • 8Karnath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease[J]. Hepatology, 2001, 33(2): 464-470.
  • 9Shavit L, Manilov R, Wiener-Well Y, et al. Urinary neutrophil gelatinase-associated lipocalin for early detection of acute kidney injury in geriatric patients with urinary tract infection treated by colistin[J]. Clin Nephrol, 2013, 80(6): 405-416.
  • 10Gerbes AL, Benesic A, Vogeser M, et al. Serum neutrophil gelatinase-associated lipoealin - a sensitive novel marker of renal impairment in liver cirrhosis?[J]. Digestion, 2011, 84(1): 82-83.

二级参考文献18

  • 1Muhammed Ashraf Memon,Nick Butler,Breda Memon.The issue of lymphadenectomy during laparoscopic gastrectomy for gastric carcinoma[J].World Journal of Gastrointestinal Oncology,2010,2(2):65-67. 被引量:10
  • 2Salerno F,Gerbes A,Gines P,et al.Diagnosis,prevention and treat-ment of hepatorenal syndrome in cirrhosis[J].Gut,2007,56(9):1310.
  • 3Schepke M,Appenrodt B,Heller J,et al.Prognostic factors for pa-tients with cirrhosis and kidney dysfunction in the era of MELD:results of a prospective study[J].Liver Int,2006,26:834-839.
  • 4Alessandria C,Ozdogan O,Guevara M,et al.MELD score and clinical type predict prognosis in hepatorenal syndrome:relevance to liver trans-plantation[J].Hepatology,2004,41:1282-1289.
  • 5Alessandria C,Ozdogan O,Guevara M,et al.MELD score and clinical type predict prognosis in hepatorenal syndrome:relevance to liver trans-plantation[J].Hepatology,2005,41(6):1282-1289.
  • 6严颖,麦丽,林炳亮,江元森,赵志新,高志良.肝肾综合征121例COX生存分析[J].中山大学学报(医学科学版),2006,27(B04):183-185. 被引量:4
  • 7Wei-guo Zhu,Da-fu Xua,Jun Pu,Cheng-dong Zong,Tao Li,Guang-zhou Tao,Fu-zhi Ji,Xi-lei Zhou,Ji-hua Han,Cheng-shi Wang,Chang-hua Yu,Jiang-guo Yi,Xi-long Su,Jin-xia Ding.A randomized, controlled, multicenter study comparing intensity-modulated radiotherapy plus concurrent chemotherapy with chemotherapy alone in gastric cancer patients with D2 resection[J]. Radiotherapy and Oncology . 2012 (3)
  • 8Mun Ki Choi,Gwang Ha Kim,Do Youn Park,Geun Am Song,Dong Uk Kim,Dong Yup Ryu,Bong Eun Lee,Jae Hoon Cheong,Mong Cho.Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a single-center experience[J]. Surgical Endoscopy . 2013 (11)
  • 9Andrea Coratti,Mario Annecchiarico,Michele Di Marino,Edoardo Gentile,Francesco Coratti,Pier Cristoforo Giulianotti.Robot-assisted Gastrectomy for Gastric Cancer: Current Status and Technical Considerations[J].World Journal of Surgery.2013(12)
  • 10Benjamin Schmidt,Nicole Look-Hong,Ugwuji N. Maduekwe,Kevin Chang,Theodore S. Hong,Eunice L. Kwak,Gregory Y. Lauwers,David W. Rattner,John T. Mullen,Sam S. Yoon.Noncurative Gastrectomy for Gastric Adenocarcinoma Should only be Performed in Highly Selected Patients[J].Annals of Surgical Oncology.2013(11)

共引文献122

同被引文献72

  • 1郑卫萍.肝硬化急性肾损伤患者的肾脏生物学标志物与鉴别诊断[J].实用器官移植电子杂志,2014,2(3). 被引量:6
  • 2郑卫萍.CKD-EPI肌酐-胱抑素C公式估算肾小球滤过率在肝硬化患者肾功能评估中的应用[J].实用器官移植电子杂志,2014,2(3). 被引量:1
  • 3王洪玲,田洁,韩涛.失代偿性肝硬化伴发急性肾损伤的危险因素分析[J].中华肝脏病杂志,2014,22(6). 被引量:5
  • 4滕大洪,郑虹.肝肾联合移植进展[J].实用器官移植电子杂志,2014,2(6):378-382. 被引量:6
  • 5邢直直.腹水[M]//郑明华.Sherlock肝胆病学.北京:人民卫生出版社,2014:205-208.
  • 6American Association for the Study of Liver Diseases (AASLD). Management of adult patients with aseites due to cirrhosis: update 2012 [EB/OL]. (2013-02-27) [2015-10-08]. http://www.guideline. gov/content.aspx?id=45103.
  • 7Angeli P, Gines P, Wong F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites [J]. Gut, 2015, 64 (4): 531-537. DOI: 10.1136/gutjnl-2014-308874.
  • 8Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury [J]. Crit Care, 2007, 11 (2): R31. DOI: 10.1186/cc5713.
  • 9Khwaja A. KDIGO Clinical Practice Guidelines for Acute Kidney Injury [J]. Nephron Clin Pract, 2012, 120 (4): c179-184. DOI: 10.1159/000339789.
  • 10Low G, Alexander GJ, Lomas DJ. Hepatorenal syndrome: aetiology, diagnosis, and treatment [J]. Gastroenterol Res Pract, 2015, 2015 : 207012. DOI: 10.1155/2015/207012.

引证文献4

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部